GT Biopharma Other Operating Expenses (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.66 -0.03 (-3.71%) USD | NASDAQ | Jan 14, 16:00

0.7454 +0.09 (+12.94%) After-Hours: 04:51

View Other Operating Expenses (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
SELLAS Life Sciences Group, Inc.	--
Lyell Immunopharma, Inc.	Upgrade
Plus Therapeutics, Inc.	Upgrade
Geron Corp.	--